Melissa B. Epperly, Chief Financial Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 5,866 shares at $46.51 ($273K) on 2020-11-23, disclosed to the SEC on 2020-11-25.
Open-market sale of $273k ZNTL by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.51 | 2,783 | $129K | 47.4% |
| 2 | $46.51 | 2,783 | $129K | 47.4% |
| 3 | $47.26 | 300 | $14K | 5.2% |
| Total | $46.55 avg | 5,866 | $273K | 100% |
| Filing → |
| ROIV | SELL | 2026-07-01 | $610K | — | Filing → |
| ROIV | SELL | 2026-03-18 | $1.2M | — | Filing → |
| ZNTL | SELL | 2024-02-12 | $29K | — | Filing → |